Benzoyl Peroxide Patent Expiration

Benzoyl Peroxide is Used for treating inflammatory lesions of rosacea in adults. It was first introduced by Galderma Laboratories Lp in its drug Epsolay on Apr 22, 2022.


Benzoyl Peroxide Patents

Given below is the list of patents protecting Benzoyl Peroxide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Epsolay US11628155 Method for therapeutic treatment of rosacea Dec 27, 2040 Galderma Labs Lp
Epsolay US11426378 Method for long-term treatment of rosacea Aug 18, 2040 Galderma Labs Lp
Epsolay US10933046 Method for treatment of rosacea in patients aged 65 years and older Feb 19, 2040 Galderma Labs Lp
Epsolay US10945987 Method for providing early onset of action in the treatment of rosacea Feb 19, 2040 Galderma Labs Lp
Epsolay US11541026 Method for treatment of rosacea Feb 19, 2040 Galderma Labs Lp
Epsolay US11865100 Method for treatment of rosacea in patients aged 65 years and older Feb 19, 2040 Galderma Labs Lp
Epsolay US11877997 Method for providing early onset of action in the treatment of rosacea Feb 19, 2040 Galderma Labs Lp
Epsolay US11986456 Method for treatment of rosacea Feb 19, 2040 Galderma Labs Lp
Epsolay US9687465 Compositions for the treatment of rosacea Nov 27, 2032 Galderma Labs Lp
Epsolay US9868103 Metal oxide coating of water insoluble ingredients Aug 08, 2028 Galderma Labs Lp



Benzoyl Peroxide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List